Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Douglas Fish to Microbial Sensitivity Tests

This is a "connection" page, showing publications Douglas Fish has written about Microbial Sensitivity Tests.

 
Connection Strength
 
 
 
1.058
 
  1. Haynes AS, Prinzi A, Silveira LJ, Parker SK, Lampe JN, Kavanaugh JS, Horswill AR, Fish D. Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections. Microbiol Spectr. 2022 08 31; 10(4):e0103922.
    View in: PubMed
    Score: 0.190
  2. Molina KC, Morrisette T, Miller MA, Huang V, Fish DN. The Emerging Role of ?-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrob Agents Chemother. 2020 06 23; 64(7).
    View in: PubMed
    Score: 0.165
  3. Kassel LE, Van Matre ET, Foster CJ, Fish DN, Mueller SW, Sherman DS, Wempe MF, MacLaren R, Neumann RT, Kiser TH. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients. Pharmacotherapy. 2018 09; 38(9):921-934.
    View in: PubMed
    Score: 0.145
  4. Moine P, Mueller SW, Schoen JA, Rothchild KB, Fish DN. Pharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese Patients. Antimicrob Agents Chemother. 2016 10; 60(10):5885-93.
    View in: PubMed
    Score: 0.127
  5. Fish DN, Kiser TH. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia. Pharmacotherapy. 2013 Oct; 33(10):1022-34.
    View in: PubMed
    Score: 0.101
  6. Fish DN. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit. Int J Antimicrob Agents. 2007 Jun; 29(6):715-23.
    View in: PubMed
    Score: 0.066
  7. Kiser TH, Hoody DW, Obritsch MD, Wegzyn CO, Bauling PC, Fish DN. Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Antimicrob Agents Chemother. 2006 Jun; 50(6):1937-45.
    View in: PubMed
    Score: 0.062
  8. Fish DN, Ohlinger MJ. Antimicrobial resistance: factors and outcomes. Crit Care Clin. 2006 Apr; 22(2):291-311, vii.
    View in: PubMed
    Score: 0.062
  9. Fish DN, Singletary TJ. Meropenem, a new carbapenem antibiotic. Pharmacotherapy. 1997 Jul-Aug; 17(4):644-69.
    View in: PubMed
    Score: 0.034
  10. Sturm AW, Allen N, Rafferty KD, Fish DN, Toschlog E, Newell M, Waibel B. Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients. Pharmacotherapy. 2014 Jan; 34(1):28-35.
    View in: PubMed
    Score: 0.026
  11. Wilson FP, Bachhuber MA, Caroff D, Adler R, Fish D, Berns J. Low cefepime concentrations during high blood and dialysate flow continuous venovenous hemodialysis. Antimicrob Agents Chemother. 2012 Apr; 56(4):2178-80.
    View in: PubMed
    Score: 0.023
  12. Karas JA, Enoch DA, Fish D, Foweraker JE. Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates from two UK hospitals over a decade. Int J Antimicrob Agents. 2010 Aug; 36(2):189-90.
    View in: PubMed
    Score: 0.020
  13. Obritsch MD, Fish DN, MacLaren R, Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother. 2004 Dec; 48(12):4606-10.
    View in: PubMed
    Score: 0.014
  14. Jung R, Fish DN, Obritsch MD, MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect. 2004 Jun; 57(2):105-11.
    View in: PubMed
    Score: 0.014
  15. North DS, Fish DN, Redington JJ. Levofloxacin, a second-generation fluoroquinolone. Pharmacotherapy. 1998 Sep-Oct; 18(5):915-35.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)